Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Kieran J Rothnie, Beade Numbere, Steven Gelwicks, Yifei Lu, Raj Sharma, Chris Compton, Afisi S Ismaila & Jennifer K Quint. (2023) Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2673-2685.
Read now
Read now
Gema Requena, Alexandrosz Czira, Victoria Banks, Robert Wood, Theo Tritton, Catherine Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J Rothnie, Felix JF Herth, Jennifer K Quint & Afisi S Ismaila. (2023) Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2039-2054.
Read now
Read now
Alexandrosz Czira, Gema Requena, Victoria Banks, Robert Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J Rothnie, Felix Herth, Jennifer K Quint & Afisi S Ismaila. (2023) Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 643-659.
Read now
Read now
Guohua Lin, Jiaqi Zheng, Pou Kuan Tang, Yu Zheng, Hao Hu & Carolina Oi Lam Ung. (2022) Effectiveness of Hospital Pharmacist Interventions for COPD Patients: A Systematic Literature Review and Logic Model. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2757-2788.
Read now
Read now
Samy Suissa, Sophie Dell’Aniello & Pierre Ernst. (2022) Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1975-1986.
Read now
Read now
David MG Halpin, Kieran J Rothnie, Victoria Banks, Alexandrosz Czira, Chris Compton, Robert Wood, Theo Tritton, Olivia Massey, Rosie Wild, Neil Snowise, Kirill Nikitin, Raj Sharma, Afisi S Ismaila & Claus F Vogelmeier. (2022) Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2417-2429.
Read now
Read now
Hannah Whittaker, Annalisa Rubino, Hana Müllerová, Tamsin Morris, Precil Varghese, Yang Xu, Enrico De Nigris & Jennifer K Quint. (2022) Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 427-437.
Read now
Read now
Kieran J Rothnie, Sandra Joksaite, Leah B Sansbury, Chris Compton, Valentina Di Boscio & Afisi S Ismaila. (2022) Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1455-1466.
Read now
Read now
Leah B Sansbury, David A Lipson, Chanchal Bains, Glenn A Anley, Kieran J Rothnie & Afisi S Ismaila. (2022) Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 415-426.
Read now
Read now
Samy Suissa, Sophie Dell’Aniello & Pierre Ernst. (2022) Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 133-141.
Read now
Read now
Samy Suissa, Sophie Dell’Aniello & Pierre Ernst. (2022) Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 109-117.
Read now
Read now
Samy Suissa, Sophie Dell’Aniello & Pierre Ernst. (2022) Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 1-9.
Read now
Read now
Leah B Sansbury, Kieran J Rothnie, Chanchal Bains, Chris Compton, Glenn Anley & Afisi S Ismaila. (2021) Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2591-2604.
Read now
Read now
Gema Requena, Daniel Dedman, Jennifer K Quint, Rebecca E Ghosh, Rachael Williams & Jeanne M Pimenta. (2021) The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 629-642.
Read now
Read now
Samy Suissa, Sophie Dell’Aniello & Pierre Ernst. (2021) Comparative Effectiveness of Initial LAMA versus LABA in COPD: Real-World Cohort Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:1, pages 1-8.
Read now
Read now
Chloe I Bloom, Ian Douglas, Omar S Usmani & Jennifer K Quint. (2020) Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 701-710.
Read now
Read now
Bethan Carter, C Verity Bennett, Jackie Bethel, Hywel M Jones, Ting Wang & Alison Kemp. (2019) Identifying cerebral palsy from routinely-collected data in England and Wales. Clinical Epidemiology 11, pages 457-468.
Read now
Read now
Chloe I Bloom, SL Elkin & JK Quint. (2019) Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 279-287.
Read now
Read now
Olorunfemi A. Oshagbemi, Frits M.E. Franssen, Suzanne van Kraaij, Dionne C.W. Braeken, Emiel F.M. Wouters, Anke H. Maitland-van der Zee, Johanna H.M. Driessen & Frank de Vries. (2019) Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD). COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 152-159.
Read now
Read now
Articles from other publishers (34)
Garyfallos Konstantinoudis, Cosetta Minelli, Holly Ching Yu Lam, Elaine Fuertes, Joan Ballester, Bethan Davies, Ana Maria Vicedo-Cabrera, Antonio Gasparrini & Marta Blangiardo. (2023) Asthma hospitalisations and heat exposure in England: a case–crossover study during 2002–2019. Thorax 78:9, pages 875-881.
Crossref
Crossref
Elsie M.F. Horne, Susannah McLean, Mohammad A. Alsallakh, Gwyneth A. Davies, David B. Price, Aziz Sheikh & Athanasios Tsanas. (2023) Defining clinical subtypes of adult asthma using electronic health records: Analysis of a large UK primary care database with external validation. International Journal of Medical Informatics 170, pages 104942.
Crossref
Crossref
Garyfallos Konstantinoudis, Cosetta Minelli, Ana Maria Vicedo-Cabrera, Joan Ballester, Antonio Gasparrini & Marta Blangiardo. (2022) Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007–2018. Thorax 77:11, pages 1098-1104.
Crossref
Crossref
Hannah Whittaker, Clementine Nordon, Annalisa Rubino, Tamsin Morris, Yang Xu, Enrico De Nigris, Hana Müllerová & Jennifer K Quint. (2022) Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study. Thorax, pages thoraxjnl-2022-219039.
Crossref
Crossref
Peter Hanlon, James Lewsey, Jennifer K Quint, Bhautesh D Jani, Barbara I Nicholl, David A McAllister & Frances S Mair. (2022) Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank. BMJ Open Respiratory Research 9:1, pages e001314.
Crossref
Crossref
Claudia Cabrera, Céline Quélen, Mario Ouwens, Katarina Hedman, Una Rigney & Jennifer K. Quint. (2022) Evaluating a Cox marginal structural model to assess the comparative effectiveness of inhaled corticosteroids versus no inhaled corticosteroid treatment in chronic obstructive pulmonary disease. Annals of Epidemiology 67, pages 19-28.
Crossref
Crossref
Chloe I. Bloom, Jukka Montonen, Olaf Jöns, Elizabeth M. Garry & Surya P. Bhatt. (2022) Treatment Transitions in Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases. Pulmonary Therapy 8:1, pages 75-93.
Crossref
Crossref
Chloe I. Bloom, Jukka Montonen, Olaf Jöns, Elizabeth M. Garry & Surya P. Bhatt. (2022) First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases. Pulmonary Therapy 8:1, pages 57-74.
Crossref
Crossref
Margaret C Smith, Helen Frances Ashdown, James Peter Sheppard, Christopher C Butler & Clare Bankhead. (2021) Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink. BMJ Open 11:12, pages e050757.
Crossref
Crossref
Samy Suissa, Sophie Dell’Aniello & Pierre Ernst. (2021) Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety. Respiratory Medicine 189, pages 106645.
Crossref
Crossref
Eleanor L Axson, Alex Bottle, Martin R Cowie & Jennifer K Quint. (2021) Relationship between heart failure and the risk of acute exacerbation of COPD. Thorax 76:8, pages 807-814.
Crossref
Crossref
Jennifer K. Quint, Caroline O’Leary, Alessandra Venerus, Ulf Holmgren, Precil Varghese & Claudia Cabrera. (2020) Development and Validation of a Method to Estimate COPD Severity in Multiple Datasets: A Retrospective Study. Pulmonary Therapy 7:1, pages 119-132.
Crossref
Crossref
Kourtney Davis & Jeanne M. Pimenta. 2021. Pragmatic Randomized Clinical Trials. Pragmatic Randomized Clinical Trials
427
442
.
Eleanor L. Axson, Kishan Ragutheeswaran, Varun Sundaram, Chloe I. Bloom, Alex Bottle, Martin R. Cowie & Jennifer K. Quint. (2020) Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis. Respiratory Research 21:1.
Crossref
Crossref
Hannah Whittaker & Jennifer K Quint. (2020) Using routine health data for research: the devil is in the detail. Thorax 75:9, pages 714-715.
Crossref
Crossref
Marjan Kerkhof, Jaco Voorham, Paul Dorinsky, Claudia Cabrera, Patrick Darken, Janwillem WH Kocks, Mohsen Sadatsafavi, Don D Sin, Victoria Carter & David B Price. (2020) Association between COPD exacerbations and lung function decline during maintenance therapy. Thorax 75:9, pages 744-753.
Crossref
Crossref
Samy Suissa, Sophie Dell’Aniello & Pierre Ernst. (2020) Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD. Chest 157:4, pages 846-855.
Crossref
Crossref
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Sabariah Noor Harun, Shahid Shah & Sameen Abbas. (2019) The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. The European Journal of Health Economics 21:2, pages 181-194.
Crossref
Crossref
Jilles M. Fermont, Charlotte E. Bolton, Marie Fisk, Divya Mohan, William Macnee, John R. Cockcroft, Carmel McEniery, Jonathan Fuld, Joseph Cheriyan, Ruth Tal-Singer, Ian B. Wilkinson, Angela M. Wood, Michael I. Polkey & Hana Müllerova. (2020) Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study. PLOS ONE 15:2, pages e0228940.
Crossref
Crossref
Philip Stone, Nikhil Sood, Johanna Feary, C Michael Roberts & Jennifer K Quint. (2020) Validation of acute exacerbation of chronic obstructive pulmonary disease (COPD) recording in electronic health records: a systematic review protocol. BMJ Open 10:2, pages e032467.
Crossref
Crossref
Matthew Johnson, Lucy Rigge, David Culliford, Lynn Josephs, Mike Thomas & Tom Wilkinson. (2019) Primary care risk stratification in COPD using routinely collected data: a secondary data analysis. npj Primary Care Respiratory Medicine 29:1.
Crossref
Crossref
C. I. Bloom, F. Ricciardi, L. Smeeth, P. Stone & J. K. Quint. (2019) Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care. BMC Medicine 17:1.
Crossref
Crossref
Maria Pikoula, Jennifer Kathleen Quint, Francis Nissen, Harry Hemingway, Liam Smeeth & Spiros Denaxas. (2019) Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records. BMC Medical Informatics and Decision Making 19:1.
Crossref
Crossref
Daniel B. Horton, Harshvinder Bhullar, Lucy Carty, Francesca Cunningham, Alexis Ogdie, Janet Sultana & Gianluca Trifirò. 2019. Pharmacoepidemiology. Pharmacoepidemiology
241
289
.
Chloe I Bloom, Ian Douglas, Jack Olney, Grainne D'Ancona, Liam Smeeth & Jennifer K Quint. (2019) Cost saving of switching to equivalent inhalers and its effect on health outcomes. Thorax 74:11, pages 1078-1086.
Crossref
Crossref
David B. Price, Jaco Voorham, Guy Brusselle, Andreas Clemens, Konstantinos Kostikas, Jeffrey W. Stephens, Hye Yun Park, Nicolas Roche & Robert Fogel. (2019) Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. npj Primary Care Respiratory Medicine 29:1.
Crossref
Crossref
Matthew Sperrin, David J. Webb, Pinal Patel, Kourtney J. Davis, Susan Collier, Alexander Pate, David A. Leather & Jeanne M. Pimenta. (2019) Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data. Pharmacoepidemiology and Drug Safety 28:10, pages 1369-1376.
Crossref
Crossref
Samy Suissa, Sophie Dell’Aniello & Pierre Ernst. (2019) Comparative Effectiveness and Safety of LABA-LAMA vs LABA-ICS Treatment of COPD in Real-World Clinical Practice. Chest 155:6, pages 1158-1165.
Crossref
Crossref
Sarah H. Landis, Jeanne M. Pimenta, Shibing Yang, Chris Compton, Neil Barnes & Guy Brusselle. (2019) Association between blood eosinophils and acute exacerbation of COPD risk in patients with COPD in primary care. Respiratory Medicine: X 1, pages 100011.
Crossref
Crossref
Shivani Padmanabhan, Lucy Carty, Ellen Cameron, Rebecca E. Ghosh, Rachael Williams & Helen Strongman. (2018) Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications. European Journal of Epidemiology 34:1, pages 91-99.
Crossref
Crossref
Olorunfemi A. Oshagbemi, Spencer J. Keene, Johanna H.M. Driessen, Rachel Jordan, Emiel F.M. Wouters, Anthonius de Boer, Frank de Vries & Frits M.E. Franssen. (2018) Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013. Respiratory Medicine 144, pages 1-6.
Crossref
Crossref
Kieran J. Rothnie, Hana Müllerová, Liam Smeeth & Jennifer K. Quint. (2018) Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice–based Population with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 198:4, pages 464-471.
Crossref
Crossref
Kieran J. Rothnie, Olivia Connell, Hana Müllerová, Liam Smeeth, Neil Pearce, Ian Douglas & Jennifer K. Quint. (2018) Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 15:8, pages 935-946.
Crossref
Crossref
Elizabeth Moore, Roger Newson, Miland Joshi, Thomas Palmer, Kieran J. Rothnie, Sally Singh, Azeem Majeed, Michael Soljak & Jennifer K. Quint. (2017) Effects of Pulmonary Rehabilitation on Exacerbation Number and Severity in People With COPD. Chest 152:6, pages 1188-1202.
Crossref
Crossref